Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 20 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.93 Insider Own30.47% Shs Outstand50.00M Perf Week-6.03%
Market Cap56.09M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float35.78M Perf Month-1.80%
Income-45.58M PEG- EPS next Q- Inst Own29.82% Short Float1.68% Perf Quarter-10.66%
Sales71.00M P/S0.79 EPS this Y- Inst Trans-2.82% Short Ratio5.57 Perf Half Y-19.26%
Book/sh1.35 P/B0.81 EPS next Y- ROA-51.80% Short Interest0.60M Perf Year-43.81%
Cash/sh1.21 P/C0.90 EPS next 5Y- ROE-112.37% 52W Range0.99 - 2.06 Perf YTD-21.58%
Dividend Est.- P/FCF- EPS past 5Y-41.99% ROI-63.47% 52W High-47.09% Beta0.76
Dividend TTM- Quick Ratio3.16 Sales past 5Y-9.65% Gross Margin15.27% 52W Low10.09% ATR (14)0.07
Dividend Ex-Date- Current Ratio3.50 EPS Y/Y TTM-590.80% Oper. Margin-56.30% RSI (14)44.75 Volatility7.98% 7.12%
Employees190 Debt/Eq0.11 Sales Y/Y TTM-36.38% Profit Margin-64.19% Recom1.00 Target Price5.50
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q74.60% Payout- Rel Volume1.68 Prev Close1.08
Sales Surprise- EPS Surprise- Sales Q/Q-50.90% Earnings- Avg Volume108.14K Price1.09
SMA20-4.43% SMA50-2.29% SMA200-14.70% Trades Volume181,485 Change0.93%
Date Action Analyst Rating Change Price Target Change
Oct-18-11Reiterated Rodman & Renshaw Mkt Outperform $7 → $5
Sep-23-09Initiated Rodman & Renshaw Mkt Outperform $14
Sep-13-07Initiated Lazard Capital Buy $19
Jun-14-24 01:18PM
Jun-13-24 09:52PM
Mar-13-24 04:40PM
04:26PM Loading…
Feb-14-24 01:49AM
Feb-01-24 08:30AM
Jan-30-24 02:55AM
Dec-15-23 10:51PM
Nov-06-23 08:00AM
Oct-30-23 04:15PM
Sep-06-23 08:30AM
06:28AM Loading…
Jul-31-23 06:28AM
Jul-24-23 04:27PM
Jun-14-23 07:21PM
Jun-08-23 08:36AM
May-22-23 09:20AM
May-14-23 10:12AM
Apr-24-23 04:05PM
Apr-17-23 06:29AM
Mar-22-23 06:04AM
Mar-21-23 10:11AM
Mar-18-23 08:02AM
Mar-16-23 04:30PM
Dec-16-22 08:47AM
05:29PM Loading…
Dec-12-22 05:29PM
Dec-07-22 06:18PM
Nov-18-22 09:31AM
Nov-08-22 06:04PM
Oct-31-22 08:30AM
Oct-20-22 08:15AM
Oct-17-22 08:51AM
Oct-14-22 07:30AM
Oct-10-22 11:31AM
Oct-06-22 08:00AM
Sep-26-22 08:00AM
Aug-30-22 12:12PM
Aug-11-22 08:00AM
Aug-03-22 08:00AM
Jul-04-22 09:00AM
Jun-11-22 10:29AM
Jun-09-22 04:30PM
Jun-06-22 08:30AM
Jun-02-22 05:05PM
May-09-22 11:57AM
Apr-19-22 08:00AM
Apr-12-22 08:30AM
Apr-06-22 04:57PM
Apr-01-22 08:00AM
Mar-28-22 04:17PM
Mar-23-22 04:41PM
Mar-21-22 08:13AM
Mar-14-22 04:10PM
Mar-10-22 08:38AM
Mar-08-22 08:29AM
Jan-22-22 08:16AM
Jan-20-22 05:38PM
Jan-14-22 09:38AM
Jan-03-22 04:10PM
Dec-15-21 04:05PM
Dec-06-21 08:38PM
Dec-02-21 04:05PM
Nov-23-21 06:26AM
Nov-09-21 10:18AM
Oct-25-21 08:00AM
Oct-21-21 08:38AM
Oct-19-21 07:00AM
Oct-18-21 08:17AM
Oct-12-21 07:00AM
Sep-28-21 08:00AM
Sep-12-21 09:35AM
Sep-02-21 04:05PM
Jul-20-21 08:00AM
Jul-14-21 02:32AM
Jun-15-21 12:00PM
Jun-09-21 04:05PM
Jun-01-21 04:05PM
May-15-21 04:24AM
May-05-21 12:05PM
Apr-21-21 08:00AM
Mar-31-21 03:41AM
Mar-17-21 04:15PM
Mar-16-21 09:59AM
Mar-15-21 04:05PM
Mar-12-21 08:00AM
Mar-04-21 08:00AM
Mar-02-21 08:00AM
Mar-01-21 04:05PM
Feb-03-21 08:30AM
Jan-30-21 03:37AM
Jan-22-21 07:26PM
Jan-20-21 08:14AM
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which engages in the manufacture, development and market of products and tools for clinical research, translational research, drug development and bioscience research. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in August 1976 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cannon KaraChief Executive OfficerFeb 21 '24Option Exercise0.0010,6400307,120Feb 27 07:22 PM